Evidence map›Paper›PMID 40016353›Full record

ArticleNature neuroscience2025

Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent T

Saef Izzy, Taha Yahya, Omar Albastaki, Hadi Abou-El-Hassan, Michael Aronchik, Tian Cao, Marilia Garcia De Oliveira, Kuan-Jung Lu, Thais G Moreira, Patrick da Silva and 18 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Saef IzzyImmunology of Brain Injury Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2822-6736
Taha YahyaImmunology of Brain Injury Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Omar AlbastakiImmunology of Brain Injury Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hadi Abou-El-HassanAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2765-291X
Michael AronchikImmunology of Brain Injury Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tian CaoImmunology of Brain Injury Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Marilia Garcia De OliveiraAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kuan-Jung LuImmunology of Brain Injury Program, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Thais G MoreiraAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Patrick da SilvaAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Masen L BoucherBoston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5972-4316
Leah C BeauchampAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Danielle S LeServeAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Wesley Nogueira BrandaoAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ana Carolina DurãoAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Toby LanserAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Federico MontiniAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Joon-Hyuk LeeAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Joshua D BernstockDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Megha KaulAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Gabriel Pasquarelli-do-NascimentoAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kusha ChopraAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rajesh KrishnanAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rebekah MannixBoston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Rafael M RezendeAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3998-8012
Francisco J QuintanaAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8156-0736
Oleg ButovskyAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0186-8867
Howard L WeinerAnn Romney Center for Neurologic Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. hweiner@rics.bwh.harvard.edu.ORCID http://orcid.org/0000-0003-0203-9681

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Targeting CNS Neuroinflammation in Traumatic Brain Injury by Nasal Anti-CD3K08NS123503 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Saef Izzy · 2022 to 2026
$1.2M
NICHD NIH HHS P50 HD105351NINDS NIH HHS K08 NS123503U.S. Department of Defense (United States Department of Defense) HT9425-24-1-0635U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 5K08NS123503-03
6 · The paper itself

Abstract

Neuroinflammation plays a crucial role in traumatic brain injury (TBI), contributing to both damage and recovery, yet no effective therapy exists to mitigate central nervous system (CNS) injury and promote recovery after TBI. In the present study, we found that nasal administration of an anti-CD3 monoclonal antibody ameliorated CNS damage and behavioral deficits in a mouse model of contusional TBI. Nasal anti-CD3 induced a population of interleukin (IL)-10-producing regulatory T cells (T

Indexed as

Antibodies, MonoclonalBrain Injuries, TraumaticCD3 ComplexInterleukin-10MicrogliaNeuroinflammatory DiseasesPhagocytosisT-Lymphocytes, RegulatoryAdministration, IntranasalAnimalsMaleMiceMice, Inbred C57BLAntibodies, MonoclonalCD3 ComplexIL10 protein, mouseInterleukin-10

Identifiers

PMID40016353
PMCPMC11893472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.